| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 39 |
| 1 | METHOTREXATE SODIUM | 29 |
| 2 | METHOTREXATE | 28 |
| 3 | ADALIMUMAB | 22 |
| 4 | INFLIXIMAB | 17 |
| 5 | PREDNISONE | 12 |
| 6 | UPADACITINIB | 10 |
| 7 | FOLIC ACID | 9 |
| 8 | MESALAMINE | 9 |
| 9 | OMEPRAZOLE MAGNESIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM HYDROXIDE | 4 | 0.2105 |
| 1 | FORMALDEHYDE | 4 | 0.0656 |
| 2 | LORATADINE TABLETS | 1 | 0.0133 |
| 3 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0045 |
| 4 | GADOXETATE DISODIUM | 1 | 0.0023 |
| 5 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 6 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0016 |
| 7 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 8 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 9 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 39 |
| 1 | Corticosteroid [EPC] | 29 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 5 | Janus Kinase Inhibitor [EPC] | 13 |
| 6 | Vitamin C [EPC] | 13 |
| 7 | Proton Pump Inhibitor [EPC] | 10 |
| 8 | Aminosalicylate [EPC] | 9 |
| 9 | Atypical Antipsychotic [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 1 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 2 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 4 | Antimalarial [EPC] | 1 | 0.0001 |
| 5 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 6 | Aminosalicylate [EPC] | 9 | 0.0001 |
| 7 | Bile Acid [EPC] | 2 | 0.0001 |
| 8 | Janus Kinase Inhibitor [EPC] | 13 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 3 | 0.0001 |